Mark Kraynak - Profile and Investment Details

Investor Profile

Mark Kraynak is a Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as TalkIQ, Stem Disintermedia, Ellevest, tEQuitable, CipherTrace, Atlas Informatics, Future Family, Rep the Squad, Pie Insurance, Vida Health, Akorda, TruSTAR, DFINITY, Co–Star, HotelTonightPredictHQ, Tara AI, Astro Technology, Deserve, BaubleBar, Balena, Kloudless, Evident, Skedaddle, Grokker, Flyp, Lensabl, Shipwell, Tari Labs, Gusto, Orkus, Edgybees, Klar, Uplevel Security, Noonlight, Silverfort, The Muse, Amino, Later, ShieldX Networks, Crew, Exabeam, Chime, Vidora, Glympse Bio, Solv, FollowAnalytics, Eden Health, The Mom Project, Indegy, hobnob, Informed.IQ, Hint Health, Birchbox, Socrates.AI, Inc., Troops.ai, UrbanSitter, Cato Networks, Mobile Action, Integris Software, YayPay, SafeChain, Worklete, Finix Payments, SKALE Labs, Qordoba, . Over time, Mark Kraynak has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Mark Kraynak is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Digital Services, Accounting, Cybersecurity, Disruptive Innovation, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Career Planning, HR Tech, Music, Strategic Partnerships, Portfolio Management, Artificial Intelligence (AI), Small and Medium Businesses, Startups, Information Technology (IT), Marketplace, Cloud Computing, Venture Fundraising, Lean Startups, Finance, Software, Biotechnology, Security Technology, Video, Entrepreneurship, Communities, Legal Tech, FinTech, Employee Benefits, Consumer Internet, Consumer Software, Consulting, Hardware, Insurance, Digital Health, Medical, SaaS, Information Technology, B2B, Therapeutics, Machine Learning, Personal Health, Healthcare Technology, Biometrics may find it worthwhile to explore potential connections with Mark Kraynak, as their portfolio suggests a familiarity and interest in this area.

Understanding Mark Kraynak’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.